National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Search
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Gestational Trophoblastic Tumors Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 06/30/2005



Description






Stage Explanation






Treatment Option Overview







Hydatidiform Mole






Placental-Site Gestational Trophoblastic Tumors






Nonmetastatic Gestational Trophoblastic Tumors






Good Prognosis Metastatic Gestational Trophoblastic Tumors






Poor Prognosis Metastatic Gestational Trophoblastic Tumors






Recurrent Gestational Trophoblastic Tumors






Get More Information From NCI






Changes to This Summary (06/30/2005)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

NIH Calendar of Events

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

President's Cancer Panel Annual Report: 2006-2007

Cancer Trends Progress Report: 2007 Update

Past Highlights
HPV Vaccines for Cervical Cancer
Hydatidiform Mole

Treatment may be one of the following:

  1. Removal of the mole using dilation and curettage (D & C) and suction evacuation.
  2. Surgery to remove the uterus (hysterectomy).

Following surgery, the doctor will follow the patient closely with regular blood tests to make sure the level of beta-HCG in the blood falls to normal levels. If the blood level of beta-HCG increases or does not go down to normal, more tests will be done to see whether the tumor has spread. Treatment will then depend on whether the patient has nonmetastatic disease or metastatic disease (see the treatment sections on metastatic or nonmetastatic disease).

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with hydatidiform mole.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov